441 related articles for article (PubMed ID: 7502594)
21. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
22. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
[TBL] [Abstract][Full Text] [Related]
23. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
Roukos DH; Lorenz M; Encke A
Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
[TBL] [Abstract][Full Text] [Related]
24. [Value of radical lymph node dissection (compartment I and II) in stomach carcinoma].
Böttcher K; Roder JD; Siewert JR
Zentralbl Chir; 1996; 121(2):131-8. PubMed ID: 8868609
[TBL] [Abstract][Full Text] [Related]
25. Extension of lymph node dissection and survival in primary gastric cancer.
Secco GB; Fardelli R; Campora E; Rovida S; Beatini M; Larghero G; Testa T; Prior C
Int Surg; 1992; 77(4):242-7. PubMed ID: 1478803
[TBL] [Abstract][Full Text] [Related]
26. The value of D1 lymphadenectomy as prognostic marker in gastric cancer.
Diaz de Liaño A; Ciga MA; Oteiza F; Aizcorbe M; Cobo F; Trujillo R; Nuin MA
Hepatogastroenterology; 2001; 48(39):895-8. PubMed ID: 11462951
[TBL] [Abstract][Full Text] [Related]
27. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection.
Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T
Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011
[TBL] [Abstract][Full Text] [Related]
28. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network.
Verlato G; Roviello F; Marchet A; Giacopuzzi S; Marrelli D; Nitti D; de Manzoni G
Ann Surg Oncol; 2009 Mar; 16(3):594-602. PubMed ID: 19118437
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
[TBL] [Abstract][Full Text] [Related]
30. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer.
Huscher CG; Mingoli A; Sgarzini G; Sansonetti A; Lirici MM; Napolitano C; Piro F
Am J Surg; 2004 Dec; 188(6):728-35. PubMed ID: 15619491
[TBL] [Abstract][Full Text] [Related]
31. [Early and late outcome of gastrectomy de principe].
Dietl F; Rumpf KD
Zentralbl Chir; 1995; 120(10):800-3. PubMed ID: 7502596
[TBL] [Abstract][Full Text] [Related]
32. Implication of extended lymph node dissection stratified for advanced gastric cancer.
Kunisaki C; Shimada H; Takahashi M; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Anticancer Res; 2003; 23(5b):4181-6. PubMed ID: 14666622
[TBL] [Abstract][Full Text] [Related]
33. [Effect of lymph node dissection on prognosis of colon carcinoma].
Klupp J; Engels S; Junginger T
Zentralbl Chir; 1995; 120(10):821-5. PubMed ID: 7502600
[TBL] [Abstract][Full Text] [Related]
34. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
35. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
36. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
37. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
[TBL] [Abstract][Full Text] [Related]
38. [The treatment of gastric tumours in our practice: a five year survey].
Ondrejka P; Bereczky B; Ráth Z; István G; Forgács B; Sugár I
Zentralbl Chir; 2004 Apr; 129(2):122-4. PubMed ID: 15106044
[TBL] [Abstract][Full Text] [Related]
39. Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count.
Giuliani A; Caporale A; Corona M; Di Bari M; Demoro M; Ricciardulli T; Gozzo P; Galati G; Tocchi A
J Exp Clin Cancer Res; 2004 Jun; 23(2):215-24. PubMed ID: 15354405
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
